BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3600197)

  • 1. Potent CNS action of calcitonin to inhibit cysteamine-induced duodenal ulcers in rat.
    Taché Y; Kolve E; Kauffman G
    Life Sci; 1987 Aug; 41(5):651-5. PubMed ID: 3600197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system action of calcitonin to alter experimental gastric ulcers in rats.
    Taché Y; Kolve E; Maeda-Hagiwara M; Kauffman GL
    Gastroenterology; 1988 Jan; 94(1):145-50. PubMed ID: 3335286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of elcatonin on experimental gastric and duodenal ulcers.
    Ohno H; Noguchi M; Takayanagi N
    Jpn J Pharmacol; 1985 Jan; 37(1):67-75. PubMed ID: 4039385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine induced-duodenal ulcers are associated with a selective depletion in gastric and duodenal calcitonin gene-related peptide-like immunoreactivity in rats.
    Evangelista S; Renzi D; Tramontana M; Surrenti C; Theodorsson E; Maggi CA
    Regul Pept; 1992 Apr; 39(1):19-28. PubMed ID: 1315979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of iron in the pathogenesis of cysteamine-induced duodenal ulceration in rats.
    Khomenko T; Szabo S; Deng X; Ishikawa H; Anderson GJ; McLaren GD
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1277-86. PubMed ID: 19342511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of prostanoids in experimental duodenal ulcer in rat.
    Kauffman GL; Kolve E; Walfisch S; Mangus J
    Dig Dis Sci; 1988 Jun; 33(6):667-72. PubMed ID: 3131076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intracisternally administered bombesin on cysteamine-induced duodenal ulcers in rats.
    Hernandez DE; Adcock JW; Nemeroff CB; Prange AJ
    Eur J Pharmacol; 1982 Oct; 84(3-4):205-9. PubMed ID: 7173320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new sigma ligand, JO 1784, on cysteamine ulcers and duodenal alkaline secretion in rats.
    Pascaud XB; Chovet M; Soulard P; Chevalier E; Roze C; Junien JL
    Gastroenterology; 1993 Feb; 104(2):427-34. PubMed ID: 8425684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirenzepine prevents cysteamine-induced formation of gastroduodenal ulcers and reduction of mesenteric circulation.
    Bernardini MC; Blandizzi C; Morini G; Chiavarini M; Impicciatore M; Del Tacca M
    Arch Int Pharmacodyn Ther; 1989; 302():242-54. PubMed ID: 2636820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of elcatonin, a synthetic analogue of eel calcitonin, on acute gastric and duodenal lesions and gastroduodenal function in rats].
    Takeuchi K; Furukawa O; Tanaka H; Nishiwaki H; Okabe S
    Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):123-33. PubMed ID: 3699626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the potential antiulcer activity of the calcium antagonist propyl-methylenedioxyindene. III. Lack of effect on cysteamine-induced duodenal ulcers in rats.
    Wong WS; Rahwan RG; Stephens RL
    Pharmacology; 1990; 41(4):215-23. PubMed ID: 2080231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cysteamine on gastroduodenal mucosal histamine in rat.
    Boesby S; Man WK; Mendez-Diaz R; Spencer J
    Gut; 1983 Oct; 24(10):935-9. PubMed ID: 6618272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from that of cimetidine.
    Morimoto Y; Shimohara K; Tanaka K; Hara H; Sukamoto T
    Jpn J Pharmacol; 1994 Mar; 64(3):221-4. PubMed ID: 8022123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers in rats.
    Kunizaki C; Sugiyama M; Tsuchiya S
    Scand J Gastroenterol Suppl; 1989; 162():218-21. PubMed ID: 2595299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of duodenal calcitonin gene-related peptide- and substance P-like immunoreactivity in rat duodenal ulcers.
    Renzi D; Evangelista S; Mantellini P; Surrenti C
    Adv Exp Med Biol; 1991; 298():129-35. PubMed ID: 1719774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of different prostaglandins on cysteamine-induced duodenal ulcer in the rat.
    Náfrádi J; Bálint GA; Varró V
    Acta Physiol Hung; 1984; 64(3-4):339-41. PubMed ID: 6397967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer.
    Szabo S; Pihan G; Gallagher GT; Brown A
    Scand J Gastroenterol Suppl; 1984; 92():106-11. PubMed ID: 6588493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tyrosine administration on duodenal ulcer induced by cysteamine in the rat.
    Oishi T; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):879-82. PubMed ID: 3559979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of various factors and drugs on cysteamine-induced duodenal ulcers in the rat.
    Fujii Y; Ishii Y
    Jpn J Pharmacol; 1975 Dec; 25(6):663-70. PubMed ID: 1228251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the hexapeptide dalargin on ornithine decarboxylase activity in the duodenal mucosa of rats in experimental duodenal ulcer].
    Iarygin KN; Shitin AG; Polonskiĭ VM; Vinogradov VA
    Biull Eksp Biol Med; 1987 Mar; 103(3):319-21. PubMed ID: 3828514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.